Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Tecan Group AG's Sloan Ratio for the quarter that ended in Dec. 2023 was 2.69%.
As of Dec. 2023, Tecan Group AG has a Sloan Ratio of 2.69%, indicating the company is in the safe zone and there is no funny business with accruals.
Tecan Group AG Sloan Ratio % Historical Data
The historical data trend for Tecan Group AG's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tecan Group AG's Sloan Ratio %
For the Medical Instruments & Supplies subindustry, Tecan Group AG's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's Sloan Ratio % falls into.
Tecan Group AG Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Tecan Group AG's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Tecan Group AG's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 54.533 (Jun. 2023 ) + 83.638 (Dec. 2023 ) = €138 Mil.
Tecan Group AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 84.526 (Jun. 2023 ) + 82.831 (Dec. 2023 ) = €167 Mil.
Tecan Group AG's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -27.674 (Jun. 2023 ) + -60.694 (Dec. 2023 ) = €-88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG (FRA:TEN) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2023, Tecan Group AG has a Sloan Ratio of 2.69%, indicating the company is in the safe zone and there is no funny business with accruals.
Tecan Group AG Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Tecan Group AG's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life science research markets. The firm operates in two segments; Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, and Partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their own names. A majority proportion of Tecan's revenue is generated in the Americas and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:TEN has been successfully added to your 